Rockwell Medical (RMTI)
NASDAQ:RMTI
Want to see RMTI full AI Analyst Report?
Earnings Data
Report Date
Aug 17, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.05Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized operational improvements (automation increasing capacity ~50%), margin expansion (gross margin +2 percentage points YoY), renewed contracts and an active customer pipeline, accompanied by concrete 2026 guidance (net sales $70–75M, gross margin 18–22%, adjusted EBITDA $1–2M, positive operating cash flow) and a clear plan to achieve positive net income in H2 2026. The primary negatives were a modest YoY revenue decline (-8% in Q1) driven by lower volumes from a prior large customer, a small Q1 net loss ($1.6M) and a slight decrease in cash due to seasonal items and a $0.5M acquisition payment. Overall, the positives around operational capacity increases, margin improvement, diversified customer base, and constructive guidance materially outweigh the modest near-term headwinds.Company Guidance
Strong Q1 Execution vs Expectations and 2026 Revenue Guidance
Net sales for Q1 2026 were $17.3 million (down 8% YoY) but exceeded internal expectations and track toward full-year guidance of $70 million to $75 million for 2026.
Improving Gross Margin and Stable Gross Profit
Gross profit for Q1 was $2.9 million (essentially flat YoY). Gross margin improved to 17% from 15% a year ago (+2 percentage points, ~+13.3% relative improvement), with sequential monthly growth in gross margin and gross profit across the quarter.
Path to Profitability and Adjusted EBITDA Progress
Management reiterated that the business has achieved adjusted EBITDA profitability in the last two years and expects the business to be profitable in 2026. Q1 adjusted EBITDA was negative $0.3M (improved from negative $0.4M a year ago). Full-year 2026 adjusted EBITDA guidance is $1 million to $2 million and management expects positive net income in the second half of 2026 (subject to customary risks).
Operational Investment to Increase Capacity and Reduce Costs
Activating two new automated liquid lines this quarter is expected to increase output by approximately 50% and significantly reduce manufacturing cost per bottle. Management estimates these changes will generate an additional $3.0 million of gross profit, about half (~$1.5 million) to be realized in 2026.
Diverse Customer Base and Global Reach
Rockwell currently serves ~300 customers representing more than 1,400 facilities, including all five leading U.S. dialysis providers, university medical centers and community hospital systems; the company supplies hemodialysis concentrates to 30+ countries and reports most customer sales concentrations are under 10%, supporting diversification and resilience.
Cash Position and Cash Flow Outlook
Cash, cash equivalents and investments available for sale were $23.9 million at March 31, 2026 (down from $25.0M at year-end). Management expects operating cash flow to be positive for 2026 and to eliminate the need to raise additional capital to fund operations.
Commercial Momentum — New Customers and Pricing Improvements
During Q1 the company added several new customers and renewed contracts with existing customers at improved pricing and product mix. Management indicated pricing adjustments have been accepted with no notable pushback to date.
RMTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RMTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $0.81 | $0.78 | -3.58% |
Mar 26, 2026 | $1.04 | $0.94 | -9.42% |
Nov 12, 2025 | $1.05 | $0.95 | -9.05% |
Aug 14, 2025 | $1.04 | $1.05 | +0.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Rockwell Medical (RMTI) report earnings?
Rockwell Medical (RMTI) is schdueled to report earning on Aug 17, 2026, After Close (Confirmed).
What is Rockwell Medical (RMTI) earnings time?
Rockwell Medical (RMTI) earnings time is at Aug 17, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMTI EPS forecast?
RMTI EPS forecast for the fiscal quarter 2026 (Q2) is -0.03.